AOK SACHSEN-ANHALT has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 27 Jun 2019. The tender notice number is 286472-2017, while the TOT Ref Number is 15109978. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 27 Jun 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 15109978

Document Ref. No. : 286472-2017

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK SACHSEN-ANHALT
Office Name: AOK Sachsen-Anhalt
Address: Lüneburger Str. 4
Town: Magdeburg
Postal Code: 39106

Attention: Sabine Eichhorn
Phone: +49 391287845301
Fax: +49 3912878845301
Germany
Email :openhouse@san.aok.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Not specified
CPV code: 33600000, 33600000
CPV Description: Conclusion of non-exclusive discount agreements pursuant to section 130a (8) SGB V on medicinal products with the active substance combination tramadol and paracetamol (ATC: N02AJ13) with a possible termination option within the framework of an "open-house model" The conclusion of non-exclusive discount agreements pursuant to - 130a para. 8 SGB V zu Arzne(ATC: N02AJ13) within the framework of an open-house model. Under the terms of uniform contractual conditions and a uniform access procedure, all appropriate and interested pharmaceutical companies or groups of pharmaceutical companies shall be required to conclude or join a pharmaceutical company Discount contract according to - 130-A para. 8 SGB V to the aforementioned active substance. Interested pharmaceutical companies can request the participation documents and the respective contract at the contact address given under I.1). The prerequisite for the conclusion of a contract is that the interested pharmaceutical company fully completes and signs the requested participation documentsT. A contract is concluded with every pharmaceutical company that fulfills the prerequisites for participation. An exclusivity is not given. The accession or conclusion of the contract may take place at any time and under the same conditions. Individual contract negotiations are not carried out. The earliest start of the contract is 1.9.2017. Out of this, theMaximum of 24 months. The contract shall end on 31 August 2019, irrespective of the commencement date of the contract.

If the AOK Sachsen-Anhalt publishes exclusive contracts for the active substances in the course of the contract period in accordance with the relevant provisions of the law, the contracts concluded pursuant to this contract shall be published in accordance with the contractual provisionsThis publication is not a public procurement contract within the meaning of - 103 GWB or of the law of consortium. In order to ensure the widest degree of transparency for the intended conclusion of the contract, the supplement is published in the Official Journal of the European Union. In the absence of a corresponding publicationGsformulars, the contract notice shall be used. The resulting conceptual specifications, such as the "open procedure" procedure, are solely due to the use of this publication form and to the publishing platformAre not binding.

Offer form.

Proof of concession
Internet address (URL):
Directive: Classical Directive (2004/18/EC)

Documents

 Tender Notice